InvestorsHub Logo
Followers 137
Posts 3718
Boards Moderated 0
Alias Born 05/10/2006

Re: None

Thursday, 09/17/2020 2:55:04 PM

Thursday, September 17, 2020 2:55:04 PM

Post# of 198788
BioClonetics said that because of the similar structures of HIV and COVID-19 and the efficacy of its Clone 3 antibody in fighting HIV, the company has been asked by the National Science Foundation @NSF to submit a funding application for development of a COVID-19 antibody. The company currently has applications pending with the NSF and the National Institutes of Health.

Remember, this was months ago. Betting they got PLENTY TO TELL IN THE NEAR TERM!!! INSANE OPPORTUNITY
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News